QA: MELINTA THERAPEUTICS INC. NEW in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001461993_2019_MELINTA_THERAPEUTICS_INC_NEW.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001461993')"}

Graph

Absolute values for 0001461993, MELINTA THERAPEUTICS INC. NEW

  xvar xval
0 AssetsCurrent 149,482,000
1 IntangibleAssetsNetIncludingGoodwill 229,196,000
2 PropertyPlantAndEquipmentNet 1,586,000
3 remainder_Assets 61,326,000
4 LiabilitiesCurrent 133,606,000
5 LiabilitiesNoncurrent 117,920,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 41,057,000
8 SellingGeneralAndAdministrativeExpense 133,312,000
9 ResearchAndDevelopmentExpense 55,409,000
10 remainder_Expenses 25,088,000
11 remainder_Revenues 96,430,000
12 remainder_NetIncome 1,244,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 441,590,000
1 Liabilities 251,526,000
2 Expenses 254,866,000
3 Revenues 96,430,000
4 StockholdersEquity 190,064,000
5 NetIncome -157,192,000
6 ComprehensiveNetIncome -157,192,000
7 BaseVar 522,828,000
8 EconomicCapitalRatio 0.490

Edgar->Model Mapping

Feature Distribution

Change over Time